Advances in antibody engineering have expanded their utility beyond single-target binding to include bispecific antibodies and engineered proteins with increased binding specificity and pharmacokinetic profiles
Protein is king right now, he said
The Lancet , 397 (10286), 1736-1748
The multiyear project was initiated by Xingya Jiang PhD19, who is now a postdoctoral research fellow at Harvard Medical School/Brigham and Womens Hospital, and was continued by Qinhan Zhou, a PhD candidate in chemistry at UT Dallas
Semaglutide works by stimulating insulin secretion, inhibiting glucagon release, slowing gastric emptying, and promoting a feeling of fullness, which helps in controlling blood sugar levels and reducing body weight
doi: 10.3390/nu14030484